AIDS Therapies

International OPTIMA Study Will Target Patients For Whom HAART Has Failed

Published in AIDS Weekly, April 9th, 2001

Researchers from the United States, Canada, and the United Kingdom are collaborating to evaluate the best treatment strategies for HIV infected patients for whom highly active antiretroviral therapy (HAART) has failed.

Representatives of the U.S. Department of Veterans Affairs (VA), the Canadian Institutes of Health Research (CIHR), and the Medical Research Council of the United Kingdom (MRC-UK) met in Washington, DC, on March 21, 2001, to complete details of a study that will begin June 1, 2001.

The study, called OPTIMA, will be the first under the three countries' Tri-National Clinical Trials Research Initiative. It will assess new therapeutic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-04-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry